Hypomethylation and high expression |
|
1 |
Chemokine signaling pathway |
1.14E−10 |
6 |
CCL18, CXCL2, CXCL1, CCL20, CXCL9, CXCL3 |
|
2 |
Ribosome |
6.80E−04 |
5 |
RPL31, PABPC1, UPF3A, RPS15A, RPS15 |
|
3 |
Nucleic acid binding |
0.0195 |
9 |
DDX49, AHR, GSTP1, RB1, AATF, DDX56, NOC2L, IMP4, DDX52 |
|
4 |
Carbon metabolism |
3.43E−04 |
5 |
GNPDA1, PFKM, ENO1, ME1, HK3 |
|
5 |
Cell cycle |
3.01E−10 |
8 |
CDC16, PKMYT1, CDC27, TFDP1, SMARCAL1, ATM, RECQL5, WEE1 |
|
6 |
Proteasome |
0.0344 |
8 |
FGFR1, SOX9, PSMD6, FOXD1, CCND1, MSX1, PSMF1, FOXA2 |
Hypermethylation and low expression |
|
1 |
Synaptic transmission |
1.04E−07 |
7 |
KCND3, KCNG1, KCNB1, HCN2, KCNK3, KCNA5, KCNA3 |
|
2 |
Gastric acid secretion |
2.19E−04 |
6 |
SST, NPY, SSTR2, CCR10, PTGER3, ADCY2 |
|
3 |
Glutamatergic synapse |
1.09E−06 |
5 |
GRIK1, GRIK2, GRIA3, GRIN2A, CAMK2B |
|
4 |
Cell fate specification |
9.20E−03 |
15 |
ARHGEF16, RHOH, TIAM1, ABR, RAP1A, NEUROD1, AR, ESR1, EGFR, TF, FEV, INPP5B, SOX17, FGD2, NKX2-2 |